Navigational, measuring, medical and control instruments manufacturing

Canada has 640 establishments in this code and it is not one market: it runs from navigation and guidance electronics through laboratory and industrial process instruments to the medical devices Statistics Canada files alongside them. What they share is the reason a better sensor is not a business. Nothing here is bought on the instrument alone. A device used to buy or sell anything by measure in Canada cannot be sold into trade until its design is approved — Measurement Canada’s own wording is that "You must obtain a type approval to confirm that a particular measuring device complies with all applicable legal requirements and can be marked for use in trade" [A] — and the medical instruments in this group face the same pattern under Health Canada. Approval attaches to the design, so each variant re-enters the queue, and the cost is sunk before a unit ships. Above that sits the engineering. Teledyne Technologies spent US$317.3M on research and development in 2025 on US$6,115.4M of sales [A], and its Instrumentation segment earned US$400.4M on US$1,457.1M — a 27.5% operating margin [A]. That margin is the point rather than a complaint about it: incumbents here are well paid, and what they are paid for is a qualification an entrant has to buy twice — once from the regulator, and again from a customer who will not put an unproven instrument into a process or a patient it cannot stop. 408 of the 640 Canadian establishments have fewer than twenty employees, so small firms plainly survive; each lives on one or two approved product lines sold to customers it already knows. Entering means funding a line all the way to approval with nothing coming in, and then doing it again for the next variant. Which niche inside the group is most reachable — process instruments, marine, or a medical device — was not tested here and is where a study would start.